StockWatch
·

IRIS Business Services Ltd Q2 FY27 Results

IRISQ2 FY27 Results
Filing
Result:Good· Market: Flat#Margin expansion#Broad based#Base effect

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue38.7418.3%35.6%
Total Income40.9316.1%31.6%
Expenditure39.158.2%35.0%
PBT1.77285.9%15.4%
Net Profit1.09212.6%99.1%
OPM4.96%10.04pp4.44pp
NPM2.67%5.43pp97.33pp
EPS0.5312.8%40.5%
View full financials

Revenue grew a strong 35.6% YoY with operating margin expansion (OPM 0.52%→4.96%), and the -99% PAT YoY move is purely a base effect from a large one-off in the year-ago quarter (net profit of ₹116.85 Cr vs PBT of only ₹2.09 Cr then), not a decline in the current core IT business.

IRIS BUSINESS SERVICES · Q2 FY27 · THE VERDICT

Revenue Growth Without Profit — IRIS's Unit Economics Unravel

IRIS delivered 35.6% revenue growth and 52% ARR expansion, beating guidance. But net profit collapsed 90% as sales & marketing spend spiralled, invalidating the prior promise of EBITDA positivity. The quarter proves the growth strategy works. It does not prove it's profitable.

13 Nov 2026 · 6 min read
Revenue

₹38.7 Cr

+35.6% YoY, +18.3% QoQ

Net Profit

₹1.1 Cr

-90% YoY from ₹11 Cr

Operating Margin

5.0%

all leverage eroded

IRIS CARBON ARR

+52%

vs 35% target

IRIS split Q2 into two starkly different stories. The topline is firing—revenue grew 35.6% year-on-year, beating the 30%+ guidance. IRIS CARBON, the company's flagship regulatory-tech SaaS, posted ARR growth of 52%, well ahead of the 35% internal target. But the bottom line is collapsing. Net profit fell to ₹1.1 Cr from ~₹11 Cr in the prior year, a 90% cliff-dive. Operating margin sits at a bare 5.0%, net margin at 2.7%. This is growth without profit, and that is the quarter's defining tension.

Where the profit went

Revenue grew 35.6% but expenses grew faster. Sales & marketing spend scaled up aggressively, particularly in developed markets (US and Europe) for the IRIS CARBON push. Management confirmed on the call that S&M expense growth outpaced revenue growth in Q2. While management asserts they're spending <$1 in S&M for every $1 of ARR earned, the delivered numbers contradict that framing: PAT down 90% despite revenue up 35.6% is the inverse of operating leverage. IRIS is in full customer-acquisition mode, treating profitable growth as a secondary concern.

Management's claims vs. what holds up

Reconciling guidance vs. delivery

Sustained 30%+ annual revenue growth

Q2 delivered 35.6% YoY growth; Q1 also exceeded 30%

Supported

SaaS ARR growth target of ~35% annually maintained

IRIS CARBON ARR up 52% from Mar 31, 2026 baseline

Supported

IRIS CARBON now has 50+ clients on disclosure management platform

Stated but not independently verified against prior cohort

Unverified but plausible

S&M spend <$1 per $1 ARR earned is efficient capital deployment

Net profit down 90% YoY despite 35.6% revenue growth—unit economics deteriorating

Overstated

EBITDA margins will expand (FY26 guidance: 'maintaining EBITDA positivity')

Management now says 'a little early to meaningfully expand'; timeline pushed to 'sooner than later'

Contradicted; guidance walked backward

What changed on this call

Three material shifts from prior FY-2026 guidance:

  • S&M spend intensity escalated. Prior guidance emphasized 'strategic investment' while promising EBITDA positivity. Q2 shows expenses now pacing ahead of revenue growth. Management held firm on the strategy but conceded ongoing margin pressure. Analyst Surender Singh directly challenged this; management defended but offered no near-term relief.

  • EBITDA expansion timeline pushed indefinitely forward. FY26 guidance promised EBITDA positivity was being maintained. Now: 'a little early to meaningfully expand' margins. That's a walk-back of credibility.

  • ARR growth deceleration risk acknowledged. Management stated growth is 'not linear' and cautioned to 'wait and see' on Q3/Q4 sustainability. H1 ARR uplift partly came from one large enterprise deal; repeatability unclear.

  • Middle East headwind is new. SupTech segment impacted by 'global economic uncertainty, especially in the Middle East.' New order intake slowed. Not flagged in prior guidance.

The bull-bear ledger

What the bears see
  • Net profit collapsed 90% YoY despite 35.6% revenue growth—worst-case operating leverage signal.

  • Management promised EBITDA positivity in FY26 guidance; now indefinitely deferred. Credibility loss.

  • One large enterprise deal inflated H1 ARR. Management admitted growth is 'not linear.' Q3/Q4 uncertainty.

  • Middle East market headwind new and ongoing. No visibility to recovery timing.

  • Stock down 62% from all-time high of ₹577 and trading below all key moving averages. Market repriced sharply.

What the bulls see
  • Revenue growth of 35.6% YoY is real and exceeds guidance. Topline firing.

  • IRIS CARBON ARR at 52% validates the SaaS strategic pivot. Well ahead of target.

  • RegTech Q2 revenue hit ₹158M, the highest ever for the segment, up 37.4% QoQ. Genuine traction.

  • 50+ clients on the IRIS CARBON disclosure management platform is a meaningful beachhead in competitive regulatory tech.

  • Management is explicitly investing for market share in developed markets. Long-term bet, not quarter-chasing.

  • Cash position 'quite comfortable' per management. Can fund the growth blitz without distress.

Risks, ranked by how much they should concern a holder

The threat matrix

Unit economics deteriorating, not improving.

HIGH

PAT down 90% YoY despite revenue +35.6% is the inverse of operating leverage. If S&M spend continues outpacing revenue, the company risks burning cash or cutting growth. Neither is attractive. Market has already priced this in—stock down 62% from ATH.

Profitability path vague; prior guidance credibility shot.

HIGH

FY26 guidance promised EBITDA positivity; Q2 shows it's been abandoned. EBITDA timeline now 'sooner than later'—which means never. Without a concrete path to profit, equity holders are betting purely on revenue/ARR growth. That's venture math for a ₹500M+ revenue public company.

ARR growth deal-dependent; linearity uncertain.

MEDIUM

One large enterprise deal inflated H1 FY27 ARR. Management admitted growth is 'not linear.' If the pipeline dries, ARR growth could decelerate sharply. Current 52% pace may not repeat.

Middle East headwind new and ongoing.

MEDIUM

SupTech segment new order intake slowed due to macro uncertainty. Not flagged in prior guidance. If conditions don't improve in H2, the headwind could persist into FY28.

S&M spend opaque by segment; capital allocation discipline unclear.

MEDIUM

Analyst pressed for S&M breakdown by segment; management deflected. That lack of transparency raises questions on whether spend is deployed efficiently or if one segment is cannibalizing margins.

How the street is positioned

Price action and valuation context: IRIS closed at ₹217 as of Nov 13, 2026. The stock is trading 62% below its all-time high of ₹577 and is below all key moving averages (SMA20: ₹208.91 above, SMA50: ₹223.57 below, SMA200: ₹242.31 below). The RSI is neutral at 51.9. Volume is increasing, signalling sellers stepping in. The 52-week range is ₹191–₹388.1; the stock trades in the lower half. The market has already priced in the profitability collapse. The steep drawdown from ATH and trading below key averages signal institutional caution.

Institutional flows: As of Q1 FY27, FII ownership was 1.76%, down 0.11pp QoQ. DII ownership was 12.08%, down 0.98pp QoQ. Promoter stake remains steady at 34.63%. The modest outflows from both cohorts suggest institutions are not fleeing, but they're not accumulating either. This is a hold-and-wait posture.

Insider/bulk activity: On Jun 19, 2026, Tunga India Long Term Equity Fund sold 1,77,627 shares at ₹276.08 per share. That was near prior highs (the stock has since fallen to ₹217). The bulk sale by a fund vehicle and the timing near highs raises a question: was it a pre-planned rebalance or a loss-cut after caution on future returns? The volume suggests a material stake reduction.

The street's own verdict: The market is saying: growth is good, but profit collapse is disqualifying. The stock has repriced 62% lower from ATH, institutions are stepping back, and the tape shows increasing seller volume. Until management shows a concrete path to profitability (not just revenue targets), the stock will likely remain range-bound or under pressure.

The debate

What to watch next

Three concrete catalysts to resolve the debate
  • 1 · Q3 FY27 EBITDA inflection

    Management said margin expansion is coming 'sooner than later.' Next quarter will reveal if that's euphemism or reality. Look for: (a) S&M growth slowing below revenue growth, (b) operating margin expanding above 5%, or (c) a specific EBITDA target re-guided. Absence of all three confirms the profitability promise is hollow.

  • 2 · IRIS CARBON ARR linearity in Q3

    The 52% growth in H1 was partly driven by one enterprise deal. If Q3 ARR growth stays above 35%, the company has a sustainable pipeline. If it drops below 30%, deal-dependency concern becomes material, and the bull case weakens significantly.

  • 3 · Middle East order intake stabilization

    SupTech segment new order intake slowed due to macro uncertainty. If H2 FY27 orders rebound (showing stabilization) or stay soft (confirming ongoing headwind), that will shape FY28 guidance and the company's ability to offset S&M pressures from other segments.

IRIS delivered a quarter that is fundamentally unsustainable. 35.6% revenue growth is excellent. 90% profit collapse is a warning. The company has chosen to sacrifice near-term profitability for market share in a regulatory-tech market that is real and large. That bet may pay off in 2–3 years if EBITDA eventually normalizes. But for now, the earnings quality is poor, the profitability path is opaque, and the street has already repriced 62% lower from ATH to reflect that reality.

The number to track from here is net margin, not revenue growth. When NPM starts moving back toward 5%+ (from today's 2.7%), the profitability question will be resolved. Until then, this is a story of potential, not execution.

Informational and educational content only. Not investment advice.